Registro Institucional de Enfermedad Tromboembólica (RIET)
Contenido principal del artículo
Resumen
.
Downloads
Detalles del artículo
Sección

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Cómo citar
Referencias
Makady A, de Boer A, Hillege H,et al. What is real-world data? A review of definitions based on literature and stakeholder interviews. Value Health. 2017;20(7):858-865. https://doi.org/10.1016/j.jval.2017.03.008. DOI: https://doi.org/10.1016/j.jval.2017.03.008
Palacios Gómez M. The quality of research with real-world informationaging. Colombia Médica. 2019;30;50(3):140-141. https://doi.org/10.25100/cm.v50i3.4259. DOI: https://doi.org/10.25100/cm.v50i3.4259
Vázquez FJ, Posadas-Martínez ML, Vicens J, et al. Incidence rate of symptomatic venous thromboembolic disease in patients from a medical care program in Buenos Aires, Argentina: a prospective cohort. Thromb J. 2013;11(1):16. https://doi.org/10.1186/1477-9560-11-16. DOI: https://doi.org/10.1186/1477-9560-11-16
Angriman F, Ferreyro BL, Posadas-Martinez ML, et al. Wells score and poor outcomes among adult patients with subsegmental pulmonary embolism: a cohort study. Clin Appl Thromb Hemost. 2015;21(6):539-545. https://doi.org/10.1177/1076029614559772. DOI: https://doi.org/10.1177/1076029614559772
Posadas-Martínez ML, Vázquez FJ, Grande-Ratti MF, et al. Inhospital mortality among clinical and surgical inpatients recently diagnosed with venous thromboembolic disease. J Thromb Thrombolysis. 2015;40(2):225-230. https://doi.org/10.1007/s11239-015-1234-2. DOI: https://doi.org/10.1007/s11239-015-1234-2
Tentoni N, Lapidus MI, Peuchot VA, et al. Bleeding events during anticoagulation in patients with hereditary hemorrhagic telangiectasia. Thromb Res. 2021;197:109-111. https://doi.org/10.1016/j.thromres.2020.10.019. DOI: https://doi.org/10.1016/j.thromres.2020.10.019
Grande Ratti MF, Posadas-Martínez ML, Vicens J, et al. Incidence of hospital-acquired venous thromboembolic disease. Rev Fac Cien Med Univ Nac Cordoba. 2018;75(2):82-87. https://doi.org/10.31053/1853.0605.v75.n2.17243. DOI: https://doi.org/10.31053/1853.0605.v75.n2.17243
Peroni HJ, Grande-Ratti MF, Vázquez FJ,et al. Efecto de las estatinas en el desarrollo de síndrome postrombótico: estudio de cohorte [Effect of statins on development of post thrombotic syndrome: cohort study]. Arch Cardiol Mex. 2020;90(4):389-397. https://doi.org/10.24875/ACM.20000341. DOI: https://doi.org/10.24875/ACM.20000341
Posadas-Martinez ML, Rojas LP, Vazquez FJ, et al. Statistical process control: a quality tool for a venous thromboembolic disease registry. J Registry Manag. 2016;43(2):82-86.
Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383(9913):267-276. https://doi.org/10.1016/S0140-6736(13)62228-X. DOI: https://doi.org/10.1016/S0140-6736(13)62228-X